[go: up one dir, main page]

US2781347A - 3-acylamidorhodanines and process for preparation - Google Patents

3-acylamidorhodanines and process for preparation Download PDF

Info

Publication number
US2781347A
US2781347A US545575A US54557555A US2781347A US 2781347 A US2781347 A US 2781347A US 545575 A US545575 A US 545575A US 54557555 A US54557555 A US 54557555A US 2781347 A US2781347 A US 2781347A
Authority
US
United States
Prior art keywords
acid
acylamidorhodanines
trithiocarbodiglycolic
grams
hydrazide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US545575A
Inventor
Richard E Strube
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to US545575A priority Critical patent/US2781347A/en
Application granted granted Critical
Publication of US2781347A publication Critical patent/US2781347A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Definitions

  • This invention relates to anorganic process and com: pounds obtained therein, and is more'particularly concerned with a process for the production..-of:.S-acylamidorhodanines and novel products thereof.:
  • the process of this invention is carriedout by reacting a carboxylic acid hydrazide with a trithiocarbodiglycolic acid in an aqueous medium to produce the correspond: ing 3-acylamidorhodanine.
  • the process may be illus trated by the following reaction scheme
  • the term acy is used herein'to designate the acyl radical of a carboxylic acid, for example, acetic, propionic, hexanoic, n-dodecanoic, benzoic, oi-naphthoic, p-nitrobenzoic, isonicotinic, phenylacetic, a-naphthyl acetic, and the like.
  • the acyl radical does not contain more than twelve carbon atoms.
  • the radicals R1 and R2 can be hydrogen or lower saturated hydrocarbyl.
  • lower saturated hydrocarbyl is used to designate saturated hydrocarbon radicals having no more than twelve carbon atoms, and is inclusive of methyl, ethyl, propyl, isopropyl, n-butyl, n-dodecyl, cyclopentyl, pheuyl, benzyl, naphthyl, and the like.
  • the acyl radical and the radicals R1 and R2 remain unchanged during the reaction.
  • 3-isonicotinarnidorhodanine can be used in substantially the same manner as. disclosed in U. S. Reissue Pa-tent 23,947; they can also be used as agricultural protectants and for this purpose can be applied as common in the art and illustrated specifically in U. S..Patent 2,635,978.
  • the reaction is advantageously carried out in water or in aqueous solution of methyl alcohol, ethyl alcohol,.
  • dioxane dioxane, tetrahydrofuran, and. the like.
  • Thereaction may be carried out attemperatures ranging between about 2,781,347 Patented Feb. 12, 1957 fifty and' 150 degrees centigrade, preferably between' and 125 degrees centigrade.
  • thereflux-temperature of thersolution at atmospheric pressure is very convenient.
  • The-trithiocarbodiglycolic acids ofthis invention can be prepared by any of the VQI'lOUSlHElllOClS described in the literature; seeBeilsteins Handbuch derOrganischen Chemie, fourth edition, 1921, vol. 3, pages 252and 291.
  • the preferred method comprises condensing potassium trithiocarbonate and the appropriate oi-halo carboxylic acidwhich has been neutralized with sodiunrorpmtassium carbonate.
  • the preferred starting material is monochloroacetic acid; it the oc,a'-(lim6thyl' derivative'is desired, then either u-brornopropionic'acid ore-chloropropionic acid'is used as starting material.
  • suitablestarting acids include a-b'romobutyric acid, a-b'romoot-bromo-a-methyl-n-butyriti acid; 0t-
  • novel compounds of this invention may be combined with solid or liquid pharmaceutical carriers and formulated into the-form of tablets, powderpackets, or
  • capsules or dissolved or suspended in suitable solvents, such as sterile water, for administration to-humans or animals.
  • suitable solvents such as sterile water
  • Example I.3-berzzamidorh0danine In a fifty milliliter round-bottomed flask, provided with a reflux condenser, was placed a solution of 0.68 gram (0.0050 mole) of benzoic acid hydrazide-in forty milliliters of water. To the solution was added 1.13 grams (0.0050 mole) of trithiocarbodiglycolic acid and the mixturewas heated on the steam bath for one hour. At that'time pale-yellow crystals-werepresent. The solutionwas cooled in an ice-bath and filtered; The prodnot was dried in vacuo at- 75 degrees centigrade and weighed 1.0 gram. Recrystallization from dilute alcohol gave 0.7 gram (55 percent) of 3-benzamidorhodanine having a slightly yellow color and" melting at 182483 degrees centigrade.
  • Example 2 (p-nz'trobenzamido) -rh0danine I grams percent) and melted at 208209 degrees cert-- tigrade with decomposition after darkening at about 204 degrees centigrade.
  • Example 3.3-isonicolinamidorhodanine In a one liter round-bottomed flask provided with a reflux condenser, were dissolved 13.7 grams (0.10 mole) of isonicotinic acid hydrazide in 100 milliliters of wa ter. The warm solution was at once added to 22.6 grams (0.10 mole) of trithiocarbodiglycolic acid dissolved in 400 milliliters of water. The solution was then heated on the steam bath for two and one half hours. After standing at room temperature for twenty hours the yellow precipitate was removed by filtration with suction and dried in vacuo over calcium chloride. The yield was 17.9 grams (70 percent).
  • the product was purified by dissolving in 25 milliliters of dimethylformarnide on the steam bath. The solution was cooled, filtered with suction and 25 milliliters of distilled Water was added to the filtrate under vigorous stirring. After cooling with ice, filtering with suction and drying in vacuo over calcium chloride, 14.0 grams (55 percent) of a slightly yellow colored product was obtained. The purification was repeated giving 12.8 grams (50 percent) of 3-isonicotinamidorhodanine melting at 196-198 degrees centigrade with decompositionand darkening slowly at a lower temperature.
  • This product 3-is0nicotinamidorhodanine, showed complete in vitro inhibition of Mycobacterium tuberculosis (H37Rv) at 0.5 milligram per milliliter.
  • In vivo tests in mice gave a maximum tolerated dose of more than 500 milligrams per kilogram per day for ten days subcutaneously and 400 milligrams per kilogram per day for ten days orally.
  • a group of mice previously infected with Mycobacterium tuberculosis (H37Rv) was treated subcutaneously with 500 milligrams of this product per kilogram per day for ten days; another group of similarly infected mice was treated orally with 200 milligrams per kilogram per day for ten days.
  • the increase in the mean survival time of the treated mice compared with the infected untreated controls was five and a half days for subcutaneous treatment and three days for oral treatment.
  • Example 4.5-methyl-3-benzamid0rh0daninc In the same manner as given in Example 1, S-methyl- 3-benzamidorhodanine is prepared by the reaction, in an aqueous solution, of benzoic acid hydrazide and a,a'dimethyltrithiocarbodiglycolic acid, the condensation product of a-bromopropionic acid and potassium trithiocarbonate.
  • Example 5 -5 ,5 -dimethyl-3 -benzamidorhdaninc
  • 5,5-dimethyl-3-benzamidorhodanine is prepared by the reaction, in an aqueous solution, of benzoic acid hydrazide and a, x,u,a'-tetramethyltrithiocarbodiglycolic acid, the condensation product of a-bromoisobutyric acid and potassium trithiocarbonate.
  • Example 6 -ethyl-3 -is0nic0linamid0rh odanine
  • 5-ethyl-3- isonicotinamidorhodanine is prepared by the reaction, in
  • Example 7.5-phenyl3-is0nic0tinamidorhodanine Example 8.5-benzyl-3-is0nicotinamidorhodanine
  • S-benzyl- 3-isonicotinamidorhodanine is prepared by the reaction, in an aqueous solution, of isonicotinic acid hydrazide with a,a-dibenzyltrithiocarbodiglycolic acid, the condensation product of a-bromo-hydrocinnamic acid and potassium trithiocarbonate.
  • the compounds exemplified above can be used as agricultural protectants in compositions and applied as common in the art, illustrated specifically in U. S. Patent 2,635,978.
  • the compounds of this invention, especially 3-isonicotinamidorhodanine, can be used in substantially the same manner as disclosed in U. S. Reissue Patent 23,947.
  • a process for the production of 3-acylamidorhodanines which comprises heating a carboxylic acid bydrazide with a trithiocarbodiglycolic acid in an aqueous medium to produce the corresponding 3-acylamidorhodanine.
  • Acyl is the acyl radical of a carboxylic acid having no more than twelve carbon atoms
  • R1 and R2 are selected from the group consisting of hydrogen and saturated hydrocarbyl radicals having no more than twelve carbon atoms, which comprises reacting a trithiocarbodiglycolic acid of the formula:
  • R1 and R2 are as above defined, with the hydrazide of a carboxylic acid having no more than twelve carbon atoms in an aqueous medium, to produce the corresponding 3-acylamidorhodanine.
  • a process for the production of 3-benzamidorhodanine which comprises heating benzoic acid hydrazide with trithiocarbodiglycolic acid in an aqueous medium to produce 3-benzamid0rhodanine.
  • a process for the production of 3-(p-ni-trobenzamido)-rhodanine which comprises reacting p-nitrobenzoic acid hydrazide with trithiocarbodiglycolic acid in an aqueous medium to produce 3-(p-nitrobenzamido)- rhodanine.
  • a process for the production of 3-isonicotinamidorhodanine which comprises reacting isonicotinic acid hy- 5 drazide with trithiocarbodiglycolic acid in an aqueous 8.
  • S-(p-ni-trobenzamido)-rhodanine. medium to produce 3-isonicotinamidorhodanine.
  • 3-acylamidorhodanines wherein the acylamido radical is selected from the group consisting of benzamido, References Cited in the file of this Patent p-nitrobenzamido andisonicofinamido radicals 5 Sytnik et al.: Chem. Abst., vol. 46, C018. 7445-46 7. 3-benzamidorhodanine. (1952).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

United States Patent S-ACYLAMIDORHODANINES PROCESS FOR PREPARATION Richard E. Strobe, Kalamazoo, Michr, assignor to The Upjohn Company, Kalamazoo, Mich, a corporation of Michigan No Drawing. Application November 7, 1955, Serial No. 545,575-
9 Claims. (Cl. 260-295) This invention relates to anorganic process and com: pounds obtained therein, and is more'particularly concerned with a process for the production..-of:.S-acylamidorhodanines and novel products thereof.:
It is an object of this invention to provide anovel and.
useful process for the production. ofj3-acylamidorhodanines. Another object is the provision of novel and useful 3-acylamidorhodanines. Other objects of this. invention will be apparent to those skilled in the art towhich this invention pertains'.
The process of this invention is carriedout by reacting a carboxylic acid hydrazide with a trithiocarbodiglycolic acid in an aqueous medium to produce the correspond: ing 3-acylamidorhodanine. The process may be illus trated by the following reaction scheme The term acy is used herein'to designate the acyl radical of a carboxylic acid, for example, acetic, propionic, hexanoic, n-dodecanoic, benzoic, oi-naphthoic, p-nitrobenzoic, isonicotinic, phenylacetic, a-naphthyl acetic, and the like. Advantageously, the acyl radical does not contain more than twelve carbon atoms. The radicals R1 and R2 can be hydrogen or lower saturated hydrocarbyl.
' The term lower saturated hydrocarbyl is used to designate saturated hydrocarbon radicals having no more than twelve carbon atoms, and is inclusive of methyl, ethyl, propyl, isopropyl, n-butyl, n-dodecyl, cyclopentyl, pheuyl, benzyl, naphthyl, and the like. The acyl radical and the radicals R1 and R2 remain unchanged during the reaction.
The process of this invention is useful in preparing 3- acylamidorhodanines as exemplified in the examples hereinafter set forth, which have antibacterial, antifungal and antinematodal activity. Thus, 3-acylamidorhodanines prepared by the process of this invention,
especially 3-isonicotinarnidorhodanine, can be used in substantially the same manner as. disclosed in U. S. Reissue Pa-tent 23,947; they can also be used as agricultural protectants and for this purpose can be applied as common in the art and illustrated specifically in U. S..Patent 2,635,978.
The reaction is advantageously carried out in water or in aqueous solution of methyl alcohol, ethyl alcohol,.
dioxane, tetrahydrofuran, and. the like. Thereaction may be carried out attemperatures ranging between about 2,781,347 Patented Feb. 12, 1957 fifty and' 150 degrees centigrade, preferably between' and 125 degrees centigrade. In many instances, thereflux-temperature of thersolution at atmospheric pressure is very convenient.
The-trithiocarbodiglycolic acids ofthis invention can be prepared by any of the VQI'lOUSlHElllOClS described in the literature; seeBeilsteins Handbuch derOrganischen Chemie, fourth edition, 1921, vol. 3, pages 252and 291. The preferred method comprises condensing potassium trithiocarbonate and the appropriate oi-halo carboxylic acidwhich has been neutralized with sodiunrorpmtassium carbonate. Thus, if unsubstituted trithiocarbodiglycolic acid is desired, the preferred starting material is monochloroacetic acid; it the oc,a'-(lim6thyl' derivative'is desired, then either u-brornopropionic'acid ore-chloropropionic acid'is used as starting material. Other suitablestarting acids include a-b'romobutyric acid, a-b'romoot-bromo-a-methyl-n-butyriti acid; 0t-
isobutyric acid, bromo-n-valeric acid, wbrcmoisovaleric acid, a-bromohexanoic acid, a-bromophenylacetic acid, u-bromohydrm cinnamic acid, Ct-blOIllOdOClECfll'lOlC acid, a-bromotetra-' decanoic acid, e-bromo-a(1-naphthyl)-acetic acid and'the like; These acids give the corresponding substituted trithiocarbodiglycolic acids.
The novel compounds of this inventionmay be combined with solid or liquid pharmaceutical carriers and formulated into the-form of tablets, powderpackets, or
capsules, or dissolved or suspended in suitable solvents, such as sterile water, for administration to-humans or animals.
The following examples are illustrative of'the present invention but are not to be construed as limiting:-
Example I.3-berzzamidorh0danine In a fifty milliliter round-bottomed flask, provided with a reflux condenser, was placed a solution of 0.68 gram (0.0050 mole) of benzoic acid hydrazide-in forty milliliters of water. To the solution was added 1.13 grams (0.0050 mole) of trithiocarbodiglycolic acid and the mixturewas heated on the steam bath for one hour. At that'time pale-yellow crystals-werepresent. The solutionwas cooled in an ice-bath and filtered; The prodnot was dried in vacuo at- 75 degrees centigrade and weighed 1.0 gram. Recrystallization from dilute alcohol gave 0.7 gram (55 percent) of 3-benzamidorhodanine having a slightly yellow color and" melting at 182483 degrees centigrade.
Analysis.-Calcd. for CmHaNzOzSz: C, 47.60; H, 3.19;-
N, 11.10; S, 25.41. S, 25.73.
This product, 3-benzamidorhodanine, showedcomple'te in vitro inhibition of Mycobacterium tuberculosis (H37Rv) at 0.5 milligram per milliliter.
Found: C,'47.98;H, 3.22; N, 11.69;
Example 2 .3- (p-nz'trobenzamido) -rh0danine I grams percent) and melted at 208209 degrees cert-- tigrade with decomposition after darkening at about 204 degrees centigrade.
By concentrating the mother liquor in vacuo toabout milliliters, 1.2 grams of. the 3-(p-nitrobenzamido)- rhodanine could be isolated, increasing the yield to 93 percent.
Analysis.-Calcd. for C10H7N3O4S2: C, 40.39; H, 2.37; N, 14.14; S, 21.57. Found: C, 40.97; H, 2.41; N, 14.15; S, 21.85.
The infrared spectrum was in agreement with the structure of this compound.
This product, 3-(p-nitrobenzamido)-rhodanine, showed complete in vitro inhibition of Mycobacterium tuberculosis (H37Rv) at 0.5 milligram per milliliter.
Example 3.3-isonicolinamidorhodanine In a one liter round-bottomed flask provided with a reflux condenser, were dissolved 13.7 grams (0.10 mole) of isonicotinic acid hydrazide in 100 milliliters of wa ter. The warm solution was at once added to 22.6 grams (0.10 mole) of trithiocarbodiglycolic acid dissolved in 400 milliliters of water. The solution was then heated on the steam bath for two and one half hours. After standing at room temperature for twenty hours the yellow precipitate was removed by filtration with suction and dried in vacuo over calcium chloride. The yield was 17.9 grams (70 percent). The product was purified by dissolving in 25 milliliters of dimethylformarnide on the steam bath. The solution was cooled, filtered with suction and 25 milliliters of distilled Water was added to the filtrate under vigorous stirring. After cooling with ice, filtering with suction and drying in vacuo over calcium chloride, 14.0 grams (55 percent) of a slightly yellow colored product was obtained. The purification was repeated giving 12.8 grams (50 percent) of 3-isonicotinamidorhodanine melting at 196-198 degrees centigrade with decompositionand darkening slowly at a lower temperature.
Analysis.Calcd. forCsHvNsozsz: C, 42.67; H, 2.78; N, 16.59; S, 25.32. Found: C, 43.04; H, 2.25; N, 16.56; S, 24.92.
The infrared spectrum was in agreement with the expected formula.
This product, 3-is0nicotinamidorhodanine, showed complete in vitro inhibition of Mycobacterium tuberculosis (H37Rv) at 0.5 milligram per milliliter. In vivo tests in mice gave a maximum tolerated dose of more than 500 milligrams per kilogram per day for ten days subcutaneously and 400 milligrams per kilogram per day for ten days orally. A group of mice previously infected with Mycobacterium tuberculosis (H37Rv) was treated subcutaneously with 500 milligrams of this product per kilogram per day for ten days; another group of similarly infected mice was treated orally with 200 milligrams per kilogram per day for ten days. The increase in the mean survival time of the treated mice compared with the infected untreated controls was five and a half days for subcutaneous treatment and three days for oral treatment.
Example 4.5-methyl-3-benzamid0rh0daninc In the same manner as given in Example 1, S-methyl- 3-benzamidorhodanine is prepared by the reaction, in an aqueous solution, of benzoic acid hydrazide and a,a'dimethyltrithiocarbodiglycolic acid, the condensation product of a-bromopropionic acid and potassium trithiocarbonate.
Example 5 .-5 ,5 -dimethyl-3 -benzamidorhdaninc In the same manner as given in Example 1, 5,5-dimethyl-3-benzamidorhodanine is prepared by the reaction, in an aqueous solution, of benzoic acid hydrazide and a, x,u,a'-tetramethyltrithiocarbodiglycolic acid, the condensation product of a-bromoisobutyric acid and potassium trithiocarbonate.
Example 6 -ethyl-3 -is0nic0linamid0rh odanine In the same manner as given in Example 3, 5-ethyl-3- isonicotinamidorhodanine is prepared by the reaction, in
an aqueous solution, of isonicotinic acid hydrazide and one'-diethyltrithiocarbodiglycolic acid, the condensation product of a-bromo-n-butyric acid and potassium trithiocarbonate.
Example 7.5-phenyl3-is0nic0tinamidorhodanine Example 8.5-benzyl-3-is0nicotinamidorhodanine In the same manner as given in Example 3, S-benzyl- 3-isonicotinamidorhodanine is prepared by the reaction, in an aqueous solution, of isonicotinic acid hydrazide with a,a-dibenzyltrithiocarbodiglycolic acid, the condensation product of a-bromo-hydrocinnamic acid and potassium trithiocarbonate.
The compounds exemplified above can be used as agricultural protectants in compositions and applied as common in the art, illustrated specifically in U. S. Patent 2,635,978. The compounds of this invention, especially 3-isonicotinamidorhodanine, can be used in substantially the same manner as disclosed in U. S. Reissue Patent 23,947.
It is to be understood that the invention is not to be limited to the exact details of operation or exact compounds shown and described, as obvious modifications and equivalents will be apparent to one skilled in the art, and the invention is therefore to be limited only by the scope of the appended claims.
I claim:
1. A process for the production of 3-acylamidorhodanines, which comprises heating a carboxylic acid bydrazide with a trithiocarbodiglycolic acid in an aqueous medium to produce the corresponding 3-acylamidorhodanine.
2. A process for the production of 3-acylamidorhodanines of the formula:
wherein Acyl is the acyl radical of a carboxylic acid having no more than twelve carbon atoms, and R1 and R2 are selected from the group consisting of hydrogen and saturated hydrocarbyl radicals having no more than twelve carbon atoms, which comprises reacting a trithiocarbodiglycolic acid of the formula:
wherein R1 and R2 are as above defined, with the hydrazide of a carboxylic acid having no more than twelve carbon atoms in an aqueous medium, to produce the corresponding 3-acylamidorhodanine.
3. A process for the production of 3-benzamidorhodanine which comprises heating benzoic acid hydrazide with trithiocarbodiglycolic acid in an aqueous medium to produce 3-benzamid0rhodanine.
4. A process for the production of 3-(p-ni-trobenzamido)-rhodanine which comprises reacting p-nitrobenzoic acid hydrazide with trithiocarbodiglycolic acid in an aqueous medium to produce 3-(p-nitrobenzamido)- rhodanine.
5. A process for the production of 3-isonicotinamidorhodanine which comprises reacting isonicotinic acid hy- 5 drazide with trithiocarbodiglycolic acid in an aqueous 8. S-(p-ni-trobenzamido)-rhodanine. medium to produce 3-isonicotinamidorhodanine. 9. 3-isonic0tinamidorhodanine.
6. 3-acylamidorhodanines wherein the acylamido radical is selected from the group consisting of benzamido, References Cited in the file of this Patent p-nitrobenzamido andisonicofinamido radicals 5 Sytnik et al.: Chem. Abst., vol. 46, C018. 7445-46 7. 3-benzamidorhodanine. (1952).

Claims (1)

  1. 6. 3-ACYLAMIDORHODANINES WHEREIN THE ACYLAMINDO RADICAL IS SELECTED FROM THE GROUP CONSISTING OF BENZAMIDO, P-NITROBENZAMIDO AND ISONICOTINAMIDO RADICALS.
US545575A 1955-11-07 1955-11-07 3-acylamidorhodanines and process for preparation Expired - Lifetime US2781347A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US545575A US2781347A (en) 1955-11-07 1955-11-07 3-acylamidorhodanines and process for preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US545575A US2781347A (en) 1955-11-07 1955-11-07 3-acylamidorhodanines and process for preparation

Publications (1)

Publication Number Publication Date
US2781347A true US2781347A (en) 1957-02-12

Family

ID=24176770

Family Applications (1)

Application Number Title Priority Date Filing Date
US545575A Expired - Lifetime US2781347A (en) 1955-11-07 1955-11-07 3-acylamidorhodanines and process for preparation

Country Status (1)

Country Link
US (1) US2781347A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Similar Documents

Publication Publication Date Title
US3316147A (en) Coccidial compositions containing lower alkyl esters of 6, 7-di(lower) alkoxy-4-hydroxy-3-quinolinecarboxylic acid
US4028402A (en) Biguanide salts
US3072653A (en) 5-amino derivatives of 4-thiazolidinones and process therefor
US2734904A (en) Xcxnhxc-nh
US2951843A (en) Tetrahydrosoquinoline biguanides
JPH0393787A (en) Pharmaceutical agent having viral action or antiviral action, phospholipid derivative and method of its preparation
US2781347A (en) 3-acylamidorhodanines and process for preparation
US2149279A (en) Derivatives of pyrazine carboxylic acid and processes for their production
US3868418A (en) Novel N-(ortho- and para-nitrobenzoyl)-sulfoximine intermediates and process for their production
US3064000A (en) S-benzoylthiamine o-monophosphate and a process for preparing the same
US3325515A (en) Coumarin derivatives and their preparation
US2633466A (en) Anhydro 2-carboxylicacylamino-3, 5-diiodobenzoic acids and process
US3055910A (en) Hydrazinonitrofurylthiazoles
US2606187A (en) N-glycosido benzimidazoles and process for preparation
IL31915A (en) Thiazolines,their preparation and pharmaceutical compositions containing them
US2949464A (en) 3-amino-5-(para-hydroxy-benzylidene) rhodanine
US3060192A (en) Production of enantiomers of alphamethyl-phenethyl hydrazine and intermediate
US4264500A (en) Process of making 6-chloro-α-methyl-carbazole-2-acetic acid
US2865928A (en) Resolution of n-acyl-dl-tryptophans
GB2204579A (en) Optically active oxo-isoindolinyl derivatives
Berlin et al. Condensation of Catechol with Phenylphosphonous Dichloride. A Novel Ring-Cleavage Reaction1
US3069430A (en) p-benzoquinone-monoguanylhydrazone-mono-[4-hydroxy-thiazolyl-(2)]-hydrazone and process
US4006242A (en) Certain benzothiazoles used in the treatment of helminthiasis
US3594413A (en) Cyclopentene derivatives
US2965634A (en) Norleucine derivatives and process for producing same